🍽️ nsaid

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of nsaid On Probiotics

Rank Probiotic Impact

Bacteria Impacted by nsaid

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Acidaminococcaceae family Increases 📓 Source Study
Desulfovibrionaceae family Increases 📓 Source Study
Enterococcaceae family Increases 📓 Source Study
Erysipelotrichaceae family Increases 📓 Source Study
Absiella genus Increases 👶 Source Study
Acidaminococcus genus Increases 👶 Source Study
Allobaculum genus Increases 👶 Source Study
Allocoprobacillus genus Increases 👶 Source Study
Amedibacillus genus Increases 👶 Source Study
Amedibacterium genus Increases 👶 Source Study
Anaerorhabdus genus Increases 👶 Source Study
Beduini genus Increases 👶 Source Study
Bilophila genus Increases 👶 Source Study High Level Cause Brain Fog(Cognitive impairment)
Breznakia genus Increases 👶 Source Study
Bulleidia genus Increases 👶 Source Study
Candidatus Stoquefichus genus Increases 👶 Source Study
Catellicoccus genus Increases 👶 Source Study
Catenisphaera genus Increases 👶 Source Study
Cupidesulfovibrio genus Increases 👶 Source Study
Desulfobaculum genus Increases 👶 Source Study
Desulfocurvibacter genus Increases 👶 Source Study
Desulfocurvus genus Increases 👶 Source Study
Desulfohalovibrio genus Increases 👶 Source Study
Desulfolutivibrio genus Increases 👶 Source Study
Desulfovibrio genus Increases 👶 Source Study
Dielma genus Increases 👶 Source Study
Enterococcus genus Increases 👶 Source Study
Erysipelatoclostridium genus Increases 👶 Source Study
Erysipelothrix genus Increases 👶 Source Study
Faecalibacillus genus Increases 👶 Source Study
Faecalibaculum genus Increases 👶 Source Study
Faecalicoccus genus Increases 👶 Source Study
Faecalitalea genus Increases 👶 Source Study
Fundidesulfovibrio genus Increases 👶 Source Study
Halodesulfovibrio genus Increases 👶 Source Study
Holdemanella genus Increases 👶 Source Study
Holdemania genus Increases 👶 Source Study
Humidesulfovibrio genus Increases 👶 Source Study
Ileibacterium genus Increases 👶 Source Study
Intestinibaculum genus Increases 👶 Source Study
Lawsonia genus Increases 👶 Source Study
Longibaculum genus Increases 👶 Source Study
Longicatena genus Increases 👶 Source Study
Mailhella genus Increases 👶 Source Study
Maridesulfovibrio genus Increases 👶 Source Study
Massilicoli genus Increases 👶 Source Study
Massilimicrobiota genus Increases 👶 Source Study
Megalodesulfovibrio genus Increases 👶 Source Study
Melissococcus genus Increases 👶 Source Study
Merdibacter genus Increases 👶 Source Study
Oceanidesulfovibrio genus Increases 👶 Source Study
Oleidesulfovibrio genus Increases 👶 Source Study
Paradesulfovibrio (ex Waite et al. 2020) genus Increases 👶 Source Study
Paucidesulfovibrio genus Increases 👶 Source Study
Phascolarctobacterium genus Increases 👶 Source Study
Pilibacter genus Increases 👶 Source Study
Pseudodesulfovibrio genus Increases 👶 Source Study
Salidesulfovibrio genus Increases 👶 Source Study
Solidesulfovibrio genus Increases 👶 Source Study
Solobacterium genus Increases 👶 Source Study
Succiniclasticum genus Increases 👶 Source Study
Succinispira genus Increases 👶 Source Study
Tannockella genus Increases 👶 Source Study
Tetragenococcus genus Increases 👶 Source Study
Traorella genus Increases 👶 Source Study
Vagococcus genus Increases 👶 Source Study
Catenibacterium genus Increases 👶 Source Study
Coprobacillus genus Increases 👶 Source Study
Eggerthia genus Increases 👶 Source Study
Kandleria genus Increases 👶 Source Study
Turicibacter genus Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
Erysipelotrichaceae incertae sedis no rank Increases 👶 Source Study
unclassified Enterococcaceae no rank Increases 👶 Source Study
unclassified Erysipelotrichaceae no rank Increases 👶 Source Study
Acidaminococcales order Increases 👪 Source Study
Desulfovibrionales order Increases 👪 Source Study
Erysipelotrichales order Increases 👪 Source Study
Lactobacillales order Increases 👪 Source Study
Dielma fastidiosa species Increases ⚗️ Source Study
Solobacterium moorei species Increases ⚗️ Source Study

Impact of nsaid on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.4 -0.4
Acne 0.4 0.4
ADHD 0.3 0.6 -1
Allergic Rhinitis (Hay Fever) 0.2 -0.2
Allergies 0.8 0.8 0
Allergy to milk products 1.5 1.5
Alopecia (Hair Loss) 0.6 -0.6
Alzheimer's disease 0.8 2.6 -2.25
Ankylosing spondylitis 0.2 -0.2
Anorexia Nervosa 0.3 -0.3
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 0.6 0.6
Atrial fibrillation 0.6 0.6 0
Autism 1.8 1.2 0.5
Barrett esophagus cancer 0.8 0.8
Bipolar Disorder 1 0.2 4
Brain Trauma 0.5 0.2 1.5
Breast Cancer 0.2 -0.2
Carcinoma 0.2 0.7 -2.5
Celiac Disease 0.6 1 -0.67
Cerebral Palsy 0.2 -0.2
Chronic Fatigue Syndrome 0.2 1.3 -5.5
Chronic Kidney Disease 0.6 -0.6
Chronic Urticaria (Hives) 0.3 -0.3
Coagulation / Micro clot triggering bacteria 0.3 0.3
Colorectal Cancer 0.6 1.2 -1
Coronary artery disease 1 -1
COVID-19 0.2 2.1 -9.5
Crohn's Disease 1.5 1.8 -0.2
cystic fibrosis 0.2 0.2 0
deep vein thrombosis 0.3 0.3
Depression 0.6 3 -4
Eczema 0.2 -0.2
Endometriosis 0.2 0.2
Epilepsy 0.4 -0.4
Functional constipation / chronic idiopathic constipation 0.2 0.6 -2
Generalized anxiety disorder 0.4 -0.4
giant cell arteritis 0.2 0.2
Glioblastoma 0.2 0.2
Gout 1.1 -1.1
Graves' disease 0.9 -0.9
Halitosis 0.2 -0.2
Hashimoto's thyroiditis 0.2 0.2 0
Hidradenitis Suppurativa 0.4 -0.4
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.2 -0.2
hypercholesterolemia (High Cholesterol) 0.8 0.2 3
hyperglycemia 0.2 0.2 0
hypersomnia 0.2 0.2
hypertension (High Blood Pressure 0.8 1.6 -1
Hypoxia 0.2 -0.2
IgA nephropathy (IgAN) 0.6 0.6
Inflammatory Bowel Disease 0.2 0.6 -2
Intelligence 0.2 0.2
Irritable Bowel Syndrome 0.4 1.8 -3.5
Liver Cirrhosis 1.5 1.4 0.07
Long COVID 2.6 3 -0.15
Low bone mineral density 0.2 0.2
ME/CFS with IBS 0.2 0.2 0
ME/CFS without IBS 0.2 0.4 -1
Metabolic Syndrome 2.5 3.1 -0.24
Mood Disorders 1.6 3.4 -1.13
multiple chemical sensitivity [MCS] 0.6 0.6
Multiple Sclerosis 0.5 1 -1
Multiple system atrophy (MSA) 0.2 0.2 0
Neuropathy (all types) 0.2 -0.2
neuropsychiatric disorders (PANDAS, PANS) 0.8 0.8
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.2 0.6 -2
Obesity 1.3 2 -0.54
obsessive-compulsive disorder 0.2 0.4 -1
Osteoporosis 0.6 0.6
Parkinson's Disease 0.2 1.6 -7
Polycystic ovary syndrome 1.3 -1.3
primary biliary cholangitis 0.6 0.6
Psoriasis 0.2 0.4 -1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.8 3.1 -0.72
Rosacea 0.2 0.3 -0.5
Schizophrenia 0.8 1 -0.25
scoliosis 0.2 0.2 0
Sleep Apnea 0.6 0.6
Small Intestinal Bacterial Overgrowth (SIBO) 0.4 -0.4
Stress / posttraumatic stress disorder 0.2 1.7 -7.5
Systemic Lupus Erythematosus 0.2 1.3 -5.5
Tic Disorder 0.2 0.2 0
Type 1 Diabetes 0.4 0.2 1
Type 2 Diabetes 0.7 1.7 -1.43
Ulcerative colitis 1 1.5 -0.5
Unhealthy Ageing 0.8 -0.8

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)